PixCell Medical
Avishay Bransky, Ph.D., CEO and co-founder of PixCell, is an expert in microfluidics, with extensive industrial experience in applied physics, software and systems engineering. He is one of the inventors of the Viscoelastic Focusing technique, cell analysis methods and the microfluidic-based cartridge. Prior to his position at PixCell, Dr. Bransky served as the CEO of HemoScreen, a subsidiary of PixCell, and led R&D projects at leading Israeli high tech companies: Elscint, Qualcomm and Trellis Photonics. Dr. Bransky holds a B.A. in Physics, B.Sc. in Materials Engineering and a Ph.D. in Biomedical Engineering, all from the Technion Israel Institute of Technology.
This person is not in any offices
PixCell Medical
3 followers
PixCell Medical provides the first truly portable point-of-care blood diagnostic solution. Leveraging the company’s patented Viscoelastic Focusing technology, along with AI-powered machine vision, PixCell’s FDA-cleared and CE-cleared HemoScreen diagnostic platform shortens diagnostic results delivery from days to minutes. With just one drop of blood and within five minutes, PixCell delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians and health systems significant time and costs.